The mechanism of cerebral homeostasis is reviewed, paying particular attention to the way bloodbrain barrier, cerebrospinal fluid and cerebral blood flow contribute to the maintenance of normal intracranial pressure. The pathophysiology of raised intracranial pressure is outlined delineating the different types of cerebral oedema. Guidelines for the management of patients with raised intracranial pressure are presented as well as the techniques of intracranial pressure monitoring.
Although the subject has been of interest to many over the last 100 years,1 it is only little over 20 years since Lundberg performed the pioneer studies in the field of measurement of intracranial pressure (ICP) and recording of its wave forms. 2 During that time an increased understanding of intracranial physiology and pathology has resulted from studies in experimental animals and in cli nical trials. In tensi ve care management, facilitated by monitoring of intracranial pressure, has reduced mortality and morbidity in Reye's syndrome l and in patients with difficult saccular aneurysm. 4 The measurement of ICP is useful in the selection of some patients for surgery for hydrocephalus5~7 and craniostenosis. 7 Its value in treatment of head injury is still the subject of debate with some8~12 claiming significant improvement, whilst others Il~16 are unconvinced.
The Blood Brain Barrier
Some of the evidence that the cerebral capillaries are actively involved in selective transfer of substances into and out of the cerebral extracellular space is as follows:
1. Anatomically the capillary endothelium has "tight junctions". The cells are joined together with much smaller gaps between them than in capillaries elsewhere, indicating a mechanical barrier . 17, 18 They contain five times the mitochondria of muscle capillaries, suggesting that they are metabolically highly acti ve cells. 19 2. His tochemically, they are rich in gammaglutamyl transpeptidase and alkaline phosphatase enzymes which are found also in other metabolically active tissue such as in the gut and renal tubules. 20 3. Biochemically, the transfer of potassium across the capillary is regulated by an energydependent system. 21 The above mechanisms help control the biochemical micro-environment of neurones and neuroglia. The Third Circulation 22 The cerebrospinal fluid (CSF) is produced not only by the capillaries of the choroid plexus but by all cerebral capillaries. The blood brain barrier causes modification of the cerebral extracellular fluid so it is not an ultra filtrate as in other tissues.
In the choroid plexus adrenergic stimulation leads to a one third reduction in CSF production, probably in response to alpha adrenergic vasoconstriction and beta adrenergic inhibition of active secretion by epithelium. Production of CSF is also reduced by cholinomimetic agents suggesting the existence of a muscarinic type of receptor. 23 The fluid formed by the cerebral capillaries flows into the ventricles, and the CSF passes out of the ventricular system through the exits of the fourth ventricle, then via the subarachnoid pathways to the arachnoid granulations in the venous sinuses for absorption. CSF has at least three types of functions. 22
Internal milieu
It provides a stable chemical composition for neurones and a mechanical cushion for the brain.
Intracerebral transport
Biogenic amines injected into ventricles have specific effects. For example, dopamine injected into the third ventricle results in release of luteinising hormone and folliclestimulating hormone by the pituitary within 20 minutes.
Lymphatic role
Insulin, mannitol, albumen, globulin, dopamine, serotonin and adrenaline are among the lipid insoluble substances proven to be cleared from the brain by transport via CSF flow thus confirming the lymphatic role for CSF.
Control of Cerebral Blood Flow
As neuronal metabolism is largely aerobic, total cerebral blood flow (CBF) has to be kept relatively constant despite fluctuations in systemic arterial pressure and ICP. This is cerebral autoregulation.
Anaesthesia and Intensive Care, Vol. IX, No. 4, November, 1981 Anatomically, adrenergic and cholinergic nerve endings have been demonstrated in piaF4 and intracerebraP5 arterioles and capillaries. Stimulation of the periarterial nerve plexus causes excitatory junction potentials in the vascular smooth muscle cells and, with increased stimulation action potentials are evoked, associated with vascular contraction (Silverberg OD, Hirst ODS, Neild TO, unpublished observations). Adrenergic and cholinergic fibres are present in the choroid plexus of mammals. 23 In the rhesus monkey, there is an adrenergic centre in the locus caeruleus. Stimulation of the adrenergic mechanism results in decreased CBF, and increased water content of the brain. It is thought that the former is due to contraction of endothelial cells and diminution of the vascular lumen and the latter to widening of the "tight cellular junctions" . 26 In man or experimental animal, many physical or metabolic factors have an influence, often profound, on cerebral vasculature. Of these the three most important are systemic blood pressure, carbon dioxide and oxygen.
1. Arterial Blood Pressure. The phenomenon of autoregulation is the most important single aspect of cerebral vascular reactivity. Large and small intracranial arteries react by constriction to an increase and by dilatation to a decrease in transmural pressure. It was well described by Fog27 who used a cranial window technique to observe pial vessels directly, and noted their response to changes in systemic blood pressure. It has since been studied exhaustively, using a variety of techniques, both directly as in Fog's experiments and by measuring flow. 28 The effect of this mechanism is a tendency to maintain cerebral blood flow constant in spite of changes in systemic arterial pressure. With systemic hypertension or hypotension cerebral vascular resistance changes to maintain cerebral blood flow relatively unchanged. In normal subjects, autoregulation is effective over a systemic arterial pressure between 50 and 200 mm Hg. With pressures above this range, flow tends to increase because vessels can constrict no more (or "break-through" may occur, with a large rise in flow): below about 50 mm Hg, CBF decreases linearly with mean systemic arterial pressure down to zero (Figure 1). C.V.F. The capacity of autoregulation is lost in a variety of pathological states, notably in conditions which cause cerebral hypoxia. Common causes of failure of cerebral autoregulation include trauma, general hypoxic states, cerebral infarct, and cerebral vascular spasm. 29 In such conditions CBF tends to alter in direct proportion to systemic arterial pressure. Loss of autoregulation has been demonstrated angiographically in animal experiments 30 and clinically. 31 The mechanism of autoregulation has been the subject of much debate. The metabolic theory, that a rise in pressure leads to an initial flow increase, washing out more carbon dioxide (co 2 ) and other metabolites and hence causing vasoconstriction, is probably untenable in view of the rapidity of the response. After minor fluctuations, the flow settles down within a few seconds, indicating that a direct myogenic response to stretching of the vascular wall,32 or a neurogenically-controlled myogenic response,26 is responsible. In view of the anatomical evidence of some neural control of all intracranial vessels, it seems likely that this contributes to a resting vascular tone and maintains the constant CBF in physiological conditions.
In pathological conditions plateau waves (sustained and seemingly spontaneous rises in ICP lasting about 20 minutes) have been considered to be due to cerebral vasodilatation,2 and the fact that pontine haemorrhage may cause them suggests that in man also the vasomotor centre for cerebral vessels is in the brain stemY 2. Arterial Oxygen Tension (P a o 2 ). In the normal situation an increase in P a o 2 above normal will have little effect on CBF. However a reduction, i.e. hypoxaemia, has profound cerebral vasodilator effect, leading to an increase in CBF. The resulting rise in CBV will cause an increase in ICP.
Clinically, this effect is seen in cerebral hypoxia from any cause -for example in cerebral ischaemia due to stroke, in states of hypoperfusion due to arterial hypotension or raised ICP.
Arterial Carbon Dioxide Tension.
CBF increases by about 2.5070 of its resting value with each mm Hg increase in arterial carbon dioxide tension (PaC02) above 40 mm Hg. 34 Corresponding increases in the cerebral blood volume (CBV) and ICP occur ( Figure 2 ). The complete curve of the cO 2 response has a roughly sigmoid shape, change in CBF ceasing at very high or low PaC02. At high levels of P aco2 the flattening of the response curve is due to the vessels becoming maximally dilated. At low PaC02 other factors such as hypoxia overcome the vasoconstrictor effect of hypocapnia. The latter point is reached at a PaC02 of about 20 mm Hg, and is important clinically as dangerously low flows can be attained by severe acute reduction of PaC02. 35 In physiological states, C02 increase probably accounts for the regional increase in CBF seen when CBF is estimated in the conscious individual performing cerebral work, e.g. increased flow in occipital lobe during reading. 36 Intracerebral Steal. 37 In pathological states, where almost invariably autoregulation to blood pressure is also lost, increasing the PaC02 may cause either no change or an actual fall in CBF. There are two explanations for this phenomenon, both of which probably play a part in clinical situations.
In an area of brain pathology where there is local tissue hypoxia, the vessels may be maximally dilated. However, surrounding neural areas retain their normal vascular responses. In hypercapnia, these normal areas respond as expected with vasodilatation and a rise in flow. Vessels in the hypoxic area can dilate no further and the net effect, since there is a finite input pressure and capacity, is to "steal" blood from this area. 38 The other mechanism is related to the rise in CBV and ICP that occurs with hypercapnia. In pathological states where the ICP may be already high or compliance low, hypercapnia can cause ICP to increase to such a level that cerebral perfusion pressure is lowered; there is a fall in CBF in the pathological area where autoregulation has been 10stY Some authors believe this to be the major mechanism in all except extreme situations. 39 Such steal phenomena are the basis for the apparently paradoxical clinical use of hyperventilation and hypocapnia. Both by its effect on the brain around a pathological area and by its general effect on lowering the ICP, reducing the PaC02 can cause an increase of local CBF in areas where perfusion is critical.
Other Factors. Other products of
Anaesthesia and Intensive Care, Vol. IX, No. 4, November, 1981 cerebral metabolism such as lactate and decrease in pH will also cause vasodilatation, increasing the CBF.
These are of secondary importance, at least where the intracranial situation alone is considered, since usually the CBF will have responded more directly to one of the three factors discussed above.
CEREBRAL COMPLIANCE As the mature skull is rigid, increase in volume of its contents leads to a rise in ICP. Such a rise is reduced by compensatory mechanisms. Thin walled veins are most easily compressed and their volume is the first to be reduced. CSF may then be displaced into the spinal canal, and its rate of reabsorption increased. Lastly brain herniates through the tentorium and/or foramen magnum.
-This pressure-volume diagram shows that where the compliance is greatest at low pressure (on left) the injection of a standard bolus of mock CSF results in minimal pressure increase (PI). However, when mechanisms of compliance are almost exhausted and the pressure is rising (on right) the same volume bolus produces a dramatic rise (P2), "Intracranial volume" in this context refers to the volume of brain and CSF only.
Cerebral compliance is a measure of the reserve in these compensatory mechanisms. By measuring the increase in ICP in response to the progressive injection of mock CSF, a pressurevolume curve ( Figure 3 ) can be constructed.
At low ICP, the injection of a standard bolus of mock CSF produces a small rise in ICP. There is good compensation and the compliance of the system is high. At higher ICP, the same volume increase produces a greater ICP rise.
This concept has been used clinically to assess prognosis in the individual case, by measuring the increase in the intracranial pressure in response to a standard fluid bolus (range 0.1-1 ml). There is, however, little evidence that this technique is of value in the clinical situation as there is sometimes minimal volume pressure response (that is, pressure rise in response to a standard bolus) when the intracranial pressure is close to the systemic arterial pressure. 40 The reason may well be a technical one, i.e. the small increase in volume over a short time may not in fact reflect the compensatory intracranial reserve (cerebral compliance), or the response may be missed in the time it takes to turn the taps.
In addition this test carries risks of infection and of inducing a sustained rise in ICP.
Analysis of the CSF pulse amplitude resulting from the systemic arterial pulse pressure wave gives the same information in a noninvasive and constantly available manner. These wave forms have been analysed by spectral analysis 41 and by linking them to a volume-pressure response. 42 The repeated increases in central venous pressure associated with ventilation produce similar information. 43 By charting the intracranial pressure pulse and comparing it with a simultaneously recorded FACTORS IMPAIRING HOMEOSTASIS Many diverse pathological states will adversely affect cerebral homeostasis. In general, factors affecting the vasculature will induce rapid changes while those affecting the blood brain barrier cause a slower change. Some factors are:
Respiration
Respiration can affect intracranial pressure in several ways. Marked increase in intracranial pressure can occur in response to airway obstruction even in the absence of changes in arterial blood gases. Increased intrathoracic pressure will impede venous return, causing a rise in intracranial pressure at the same time as cerebral perfusion pressure is reduced. This can occur during coughing or nursing procedures such as turning or physiotherapy ( Figure 6 ). Rise in PaC02 or fall in Pa02 causes cerebral vasodilatation, which also increases intracranial pressure.
' - 
Vascular Injury
The sudden rise in intracranial pressure soon after concussive injury has often been thought Anaesthesia and Intensive Care, Vol. IX, No. 4, November, 1981 due to cerebral oedema. This is not so, as it has been shown in experimental animals that after moderate injury there is an immediate marked rise in ICP which quickly reverts to normal levels. 44 The logical explanation of this ICP rise is temporary vasomotor paralysis leading to vasodilation. As a corollary to this, there is no increase in water content of the brain at this early stage. 45 In children and adults deterioration occurring some hours after impact ("malignant brain oedema") has been shown to be due to vasodilation and increased cerebral blood volume as measured by the Hounsfield units on computerised axial tomography (CAT scan). 46 
Drugs
A problem in the interpretation of research data arises from the fact that most data have been gleaned from normal subjects or normal animals. Subjects with intracranial pathology may not behave in an identical manner; for example, the vasculature in and about a cerebral tumour may be relatively unresponsive to drugs and so a drug which constricts or dilates the normal intracranial vessels may cause a shift in intracranial contents with dire results to the patient due to intracranial herniation. 47 As one might expect from consideration of the mechanism of homeostasis, many drugs will have direct or indirect effects on CBF, CBV and cerebral metabolism (CMR02)'
For example opiates depress respiration, which results in an elevation of PaC02, cerebral vasodilatation, increase in CBF and rise in ICP. If the same drug however, is administered to a patient whose ventilation is controlled, there will be no change in PaC02, and the only effect of the opiate will be reduction in CMR02' Similarly the effects of barbiturates can depend on the circumstances of administration. A moderate dose of thiopentone reduces ICP by causing cerebral vasoconstriction 48 (Figure 7 ). An excessive dose can cause hypotension, cerebral hypoxia and a consequent rise in ICP. Thus in any discussion of the effects of drugs on ICP, dosage and the circumstances of administration must be considered.
(a) Inhalation Anaesthetic Agents
Nitrous oxide (N20) by itself has little effect on CBF but reduces CMR02 and raises ICP. Thiopentone induction preceding N20 administration appears to prevent this rise in ICP . 35, 49 Entonox (N20, 50070 in 02) often used to facilitate physiotherapy has been shown to elevate ICP significantly in head-injured patients. 50 Diethyl ether and cyclopropane are of historical interest only because of their flammability. Both these agents reduce CBF at low concentrations but increase it when administered in larger quantity. The ICP however is increased even during administration of low concentrations. 35 ,51 Halothane increases both CBF and ICP as does trichlorethylene. 48 ,52,53 Methoxyflurane 0.5% has little effect on ICP in normal subjects, but 1.5% will increase ICP. 54
In patients with intracranial pathology, however, even the lower concentration raises ICP. Enflurane is like halothane in most ii1tracranial effects, but some differences exist. At deep levels of anaesthesia, enflurane, as well as decreasing CMR02, can cause epileptiform cerebral activity or frank seizures. Hypocarbia directly potentiates this effect. During seizure activity, CMR02 increases by about 50%, back to about the normal, non-anaesthetised leve1. 55 It has been demonstrated in rats that enflurane almost doubles cerebrospinal fluid production,56 which correlates well with the increase in glucose utilisation in the choroid plexus during enflurane anaesthesia. 57 Isoflurane also behaves like halothane; CMR0 2 decreases and CBF increases. The latter effect is due to reduction of cerebral vascular resistance. Like the other halogenated agents, the CBF -CO 2 curve is displaced upwards, that is at any given PaC02 cerebral blood flow is greater than normal, but remains responsive to CO 2 changes. 55 ,58 In patients with intracranial space-occupying lesions both drugs can be expected to increase ICP significantly. 59 Despite hyperventilation to a PaC02 of [26] [27] [28] mm Hg, halothane, isoflurane and enflurane have been found to make brain stiffer, suggesting increased CBV, and to raise the low frequency brain electrical impedence in dogs, indicating increased brain water content. 60,61 Enflurane increases CSF outflow resistance. 56 ( 
b) Intravenous Anaesthetics and Adjuvants
Thiopentone increases cerebral vascular resistance 47 and reduces CBF, CBV and CMR0 2 . When administered in anaesthetic or higher dosage, ICP is reducedY Althesin has similar effects 63 -65 and has been found useful for neurosurgical anaesthesia. 66 Methohexitone and etomidate also lower ICP Y Pentobarbitone has been found not to influence outflow resistance. 56 Ketamine behaves very differently however. CBF is increased without decrease in CMR02, and ICP is elevated. 68 ,69 CSF outflow resistance, i.e. the resistance to CSF transfer from the subarachnoid space to the veins, is also increased. 56 Despite this, ketamine has been used widely for diagnostic procedures in patients with intracranial lesions/o but we consider that safer techniques are available, should there be any suspicion of raised ICP.
Morphine has little effect on CBF provided normocapnia 71 ,72 is maintained. It has been claimed that CMR02 is reduced but this has also been disputed. ICP as much as inhalation anaesthetics, but somewhat more than pentobarbitone alone. 75 Diazepam reduces CBF and CMR02 in head injuries 76 and reduces ICP in neurosurgical patients. 67 In experimental animals lorazepam has the same effects, and reduces ICP in the presence of intracranial hypertension. 77 ,78 Pancuronium and d-tubocurarine do not appear to affect CBF, CMR02 or ICP during normocarbia and in the absence of blood pressure changes. 35 ,79 Intravenous lignocaine has not been studied fully, but 1.5 mg/kg administered to headinjured patients lowers ICP and reduces the rise in ICP which follows endotracheal suctioning. 80 
Cerebral Oedema
In order to facilitate the understanding of this process, Klatz0 81 initially proposed that it be divided into "vasogenic" and "cytotoxic" categories, and recently a third category, "interstitial", has been added. 82 ,83 In the experimental animal, many models are used, producing some inconsistent results. We shall consider only a few selected examples as each different insult produces initially its own peculiar changes. The later leak of plasma and of denatured cell proteins into the extracellular space, however, results in a very similar end picture.
In an endeavour to see the effect of increasing only the intracerebral fluid, experiments have been designed infusing saline directly into the brain. With SOJo increase in water content, no change in autoregulation or CBF was noted. 84 In addition the blood brain barrier can be opened temporarily by hyperosmolar solutions without causing neurologic sequelae or cerebral oedema. 85 Thus the mere addition of isotonic fluid in the extracellular space produces no recordable effect until the volume is such that the ICP rises and perfusion is compromised.
Injury to the capillaries, however, results in increased amount of fluid and protein accumulating in the extracellular space, particularly in the white matter of the hemispheres. This vasogenic brain oedema is in contradistinction to the distribution of oedema in water intoxication where the swelling is most marked in the cerebral grey matter. 86 Anaesthesia and Intensive Care, Vol. IX, No. 4, November, 1981 Cold-injured animals are the usual model for vasogenic brain oedema. In these it has been shown that glucose metabolism is inhibited more widely than the area of oedema would suggest, and that the protective effect of dexamethasone is more pronounced than would be expected from its effect on the area of oedema alone. 87 The clearance of vasogenic brain oedema seems to be by bulk flow from the cortical lesion through the white matter into the ventricles. 88 -9o There is evidence, however, that it also takes place in situ, association with the removal of serum protein from the extracellular space by the astrocytes and microglia. 91 Computerised axial tomography (CAT scan) has now enabled the clinician to assess cerebral oedema objectively, so that he can judge the efficacy of treatment almost as accurately as the physiologist with an experimental model. However as the CAT scan measures the radio density of each pixel and not the water content, the concentration of other substances in the area becomes important. Protein leaked from capillaries increases the radio density and fat decreases it. So when one sees a patient with a head injury and secondary signs of swelling (distortion and obliteration of cisterns and ventricles, shift of midline structures) without reduced radio-density, it is reasonable to postulate that the decreased radio-density due to increased water content has been balanced by decreased fat and/or increased protein. 92 ,93 Oedema is detected more easily by measuring the Hounsfield units of each pixel than by comparing completed scans. 94 ,95 The oedema seen around a cerebral tumour is a clinical example of vasogenic oedema. The leakage spread is similar to that seen in experimental cold injury, but the leaked proteins cause more severe oedema, especially in the case of metastatic tumours.
Cytotoxic (or cellular) oedema follows damage to the neuronal elements. There are many causes for this. The classic experimental model utilises triethyl tin which, like hexachlorophane, cuprixone and isonicotinic acid hydrazide, produces a similar picture of widening of the intramyelinic space with minimal alterations in astrocytes or axons. The changes are maximal in the white matter. 96 In transient ischaemia or hypoxia, the damage is primarily in the bodies of the neurones and this damage can be demonstrated in the absence of gross neurological deficit, suggesting that the neuronal loss has to reach a critical level before signs are demonstrable.
Despite an heterogeneous ultrastructure early in these lesions, however, the final appearance is similar. Usually cellular oedema in humans occurs following interruption of blood supply, as in stroke or cardiac arrest. Neuronal damage is primary -there is immediately electrical silence, probably due to synaptic interruption. 97 These are thus clinical examples of cellular oedema. The anoxia primarily damages the neurones, but to a lesser extent also opens the blood brain barrier, and in stroke may release harmful substances from thrombotic material. At an early stage serotonin and glutamine may be released, which further damage the blood brain barrier and cells respectively. Other factors such as free radicals, fatty acids or lysozymal enzymes cause further damage, impairing the microcirculation. 97 In head injuries there is a multiplicity of pathological processes. An initial vasoparalysis is followed by a vasogenic oedema some time later. If the injury is more severe, cell damage and extravasation of blood add a cytotoxic (or intracellular) component. The initial impact and consequent injuries may be compounded by secondary insults, and result in patients who were conscious at some time after injury, dying later. 98 ,99 This emphasises the need for early, meticulous treatment to minimise secondary, post impact damage.
The third form of oedema, interstitial oedema, is due to the retrograde movement of CSF into the hemisphere white matter in progressive hydrocephalus. This is seen easily on CAT scan. 100 It can cause damage to the periventricular white matter. 101 
Effects of Cerebral Oedema
As with loading of the intracranial volume by any space-occupying mass, such as a haematoma or tumour, the effect of oedema is to raise the ICP. This of course can include raised pressure in the whole cranial cavity, but owing to the partly plastic, partly elastic nature of the brain, and perhaps also to the dural septa, local increases in ICP can often become significant first. 37, 102 The most important result of raised ICP is its effect on the cerebral perfusion pressure and autoregulation of the cerebral blood flow. The brain can maintain normal flow down to a mean arterial pressure of 50 mm Hg or less, but it must be emphasised that the important parameter is cerebral perfusion pressure (i.e. SAP minus ICP).I03 Thus an intracranial pressure of 50 mm Hg and arterial pressure 100 mm, has exactly the same effect on CBF as a blood pressure of 50 mm Hg with an open skull. Eventually of course when perfusion pressure is low enough, autoregulation fails. The cerebral blood flow falls and further ischaemia, resulting progressive oedema, initiates a vicious cycle. Management of Raised Intracranial Pressure 104, 105 The aim of management is to maintain the special internal environment of the neurones in optimum state, so that recovery from the pathological processes is not prejudiced, dramatically lower ICP before lowering systolic arterial pressure in well hydrated young subjects, free of cardiac disease. 9 ,l04,l16,l17 None of the above therapeutic modalities is devoid of risk, some greater than others, The objective is to keep the ICP down to a level such that the systolic arterial pressure can provide sufficient perfusion pressure.
Barbiturate Protection
The ability of barbiturates to reduce the cerebral oxygen consumption is well known. In view of the experimental evidence,118 barbiturates have been advocated in an endeavour to protect the human brain from hypoxic damage, both global and focal. More recent experiments demonstrate that barbiturates diminish cerebral damage after general cerebral hypoperfusion l19 but not after complete circulatory arrest. 120 Evidence for their efficacy in global ischaemia in man is anecdotal. 121 In one series of nine children who suffered anoxia, barbiturates controlled excessive intracranial pressure rise in seven, with two dying from cerebral hypertension. Of the seven, three subsequently died and four were vegetative. 9 . It may be that the period of anoxia was too long to expect the limited protection to be of value.
In focal ischaemia, experimental work in primates is more convincing. It has been found that: 1. in the untreated animal, six hours of middle cerebral artery occlusion followed by reestablishment of the circulation produced more neurological deficit than permanent occlusion; 2. barbiturate coma for 96 hours, induced 30 minutes after middle cerebral artery occlusion without re-establishment of the circulation, was detrimental; and 3. barbiturate coma for 96 hours, induced 30 minutes after middle cerebral artery occlusion with re-establishment of the circulation after six hours, provided nearly complete protection from ischaemic damage. 122 They could, therefore, be of use in patients who have middle cerebral artery blockage by protecting the hemisphere until a bypass procedure can be performed.
Should it be decided to utilise barbiturates, either pentobarbitone or thiopentone is suitable. The initial dose is of the order of 3 to 6 mg/kg/hr, and maintenance is by 0.5 to 3 mg/kg/hr by infusion. The electroencephalogram can be used as a guide to depth, maintaining severe burst suppression, with silence and bursts of about equal lengths. Serum barbiturate levels are usually of the order of 20 to 50 mg/l. It is essential that cerebral perfusion pressure be maintained greater than 50 mg Hg, even if vasopressors need to be used.
In addition to monitoring ICP and systolic arterial pressure, a Swan Ganz catheter may be advisable, as severe cardiovascular depression is a risk, especially in elderly or hypovolaemic patients, or those with impaired cardiac function. As clinical signs of the cerebral state cannot be elicited during "barbiturate protection", therapy is continued until dose reduction is not followed by a rise in ICP to abnormal levels. This usually takes five days or more. After such high doses of barbiturate, elimination may take several days.
Monitoring
Traditionally, patients with neurological problems have been monitored by assessment of their clinical status vital signs, neurological signs and state of consciousness. These are not always accurate, as children and young adults may tolerate raised ICP well until sudden decompensation occurs and rapid deterioration follows (Figure 8 ). The difficulty is to select the patients who would benefit from intracranial pressure monitoring. This is very much a personal decision: it is a matter of balancing the risks of the intracranial pressure monitoring against the calculated advantages. Thus the technique of monitoring the pressure is of importance.
The intraventricular catheter with the attendant risk of meningitis would be more dangerous in patients prone to infection such as those with shunts for hydrocephalus, than the extradural technique. Similarly, the extradural technique is easier to justify for routine postoperative use.
Although the advantages of intensive care management of head injuries are still debated, we feel that intracranial pressure monitoring should be used because it makes a material contribution to the logical management of this often devastating problem.
In instances where drugs are used which impair the state of consciousness and hence one's ability to assess the patient's clinical signs, it is mandatory to be able to measure the pressure, so that one has some idea of the patient's progress. Assessment of the systemic arterial pressure simultaneously is essential if barbiturates or Althesin are to be used. This then allows one to calculate the cerebral perfusion pressure by deducting the intracranial pressure from the systemic arterial pressure.
Monitoring of ICP has shown that assessment of ICP from the CAT scan is unreliable. I23 ,124 In addition ICP measurements are useful in forecasting outcome,125 and for deciding whether an intracerebral haematoma needs evacuation. 126. Other parameters must not be forgotten. The blood gases need to be checked. Should osmotic agents be used the serum osmolality must be estimated. If barbiturates are employed serum barbiturate levels should be followed.
Methods of Measuring Intracranial Pressure
All methods have specific advantages and disadvantages and most units use a variety of methods depending on the clinical situation. 127 They correlate well for practical purposes though pressure gradients may be present. 37 As well as clinical observation supplemented by recording of systemic arterial pressure, and ICP, it is invaluable to be able to visualise intracranial pathology by means of the CAT scan. This can be easily repeated to see pathological changes from time to time, as there are not the adverse side effects associated with angiography which is now infrequently used in the management of trauma. CONCLUSION In the future we expect continual refinement of the methodology of ICP measurement. Telemetric fully implantable apparatus is currently being developed; we anticipate it will be sufficiently reliable and inexpensive to be available soon for clinical use.
We can expect further refinement of the CAT scan and it is possible that positron emission tomography may assist further by demonstrating, in vivo, cerebral blood flow and metabolism the same way as the CAT scan now demonstrates anatomy. 133 Nuclear magnetic resonance scanning is another modality which shows promise in demonstrating anatomy of the intracranial contents as it can differentiate between hydrogen in water and hydrogen in organic molecules grey-white matter differentiation is better and infarcts show up more clearly than in a CAT scan. 134 Therapeutic administration of drugs such as ethacrynic acid derivatives to counteract the biochemical disturbance causing cellular oedema may prove to be of value in patients following cerebral insults. 135 
